Advances in Polyconjugate Vaccine Development: Leveraging SEC-MALS for Enhanced Quality Control and Efficacy
Presented by: Katayoun Morakabi, Ph.D, Waters | Wyatt Technology
Presented Live: March 26, 2025
The upcoming webinar will delve into the latest advancements in pneumococcal polysaccharide vaccines and pneumococcal conjugate vaccines (PCVs), focusing on their development, production, and quality control. Key topics include the introduction of a new USP general chapter for the SEC-MALS method, the challenges of serotype replacement, and the evolution of PCVs to include more serotypes. The session will explore the critical role of SEC-MALS in ensuring vaccine consistency and stability, highlighting its advantages over traditional analytical techniques, as well as the benefits of FFF-MALS for ultra-high molecular weight PCV analysis.